Lupin enters into marketing alliance with Forest Lab

Lupin Ltd., announced today that the Company has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus® line of products with Forest Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals, Inc, USA, will use its 50 person sales force to promote the product to pediatricians. AeroChamber Plus® is a Valved Holding Chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and COPD. Aerochamber Plus® also reduces the deposition of medication in the mouth and throat and makes metered dose inhalers easier for patients to use by reducing the need to coordinate actuation of the inhaler with inhalation. AeroChamber Plus® is the most widely prescribed holding chamber in the United States and has been used by millions of patients since its introduction. Approximately two thirds of AeroChamber Plus® Valved Holding Chamber prescriptions (IMS 2007 data) are written by pediatricians.